SpectraScience Inc (SCIE)

[stervc]

SCIE Intellectual Property**33 US Patents & 25 European Patents

Below are the links and key information to help one navigate and understand to actually see the huge amount of SCIE patents that they own regarding their ability to diagnose pre-cancers:

Intellectual Property
In today's world of advanced technology, a significant part of any company's assets are intangible, originating from patents, copyrights, and other legally protected intellectual property, according to Bill Roberts, writing for Knowledge Management Magazine. Intellectual property (IP) is considered one of the most significant assets of several of the world’s largest and most powerful companies. In fact, IP is the basis for market leadership and ongoing prosperity of numerous multinational organizations. In addition, IP is often the key objective in mergers and acquisitions.

With its 33 active US patents, some 25 European counterparts, continued applications and continuations SpectraScience owns the largest patent portfolio in the field of optical methods for cancer and cancer precursor discovery. These patents provide significant barriers to entry as we continue to broaden our portfolio. Here is a list:

• 13 patents related to optical biopsy forceps, scanning arrays and confocal optics
• 16 patents covering spectral analysis applications, obstructions, image normalization and calibration
• 4 imaging patents covering temporal alignment and focus

By clicking on the link below and moving your mouse on the indicated tab of topics that I have reflected below, a patent number pops up and when clicking on the patent number, the patent info pops up along with an option for more details that takes you to the actual USPTO Approved Patent within the official government database:

http://www.spectrascience.com/index.php/technology/intellectual-property

http://www.spectrascience.com/index.php/technology/intellectual-property

v/r
Sterling